Market Cap 7.59B
Revenue (ttm) 4.07B
Net Income (ttm) 560.12M
EPS (ttm) N/A
PE Ratio 6.94
Forward PE 6.16
Profit Margin 13.77%
Debt to Equity Ratio 1.49
Volume 1,010,500
Avg Vol 1,025,738
Day's Range N/A - N/A
Shares Out 60.73M
Stochastic %K 20%
Beta 0.42
Analysts Strong Sell
Price Target $193.44

Latest News on JAZZ

Jazz Pharmaceuticals to buy Chimerix for $935 million

Mar 5, 2025, 7:14 AM EST - 4 weeks ago

Jazz Pharmaceuticals to buy Chimerix for $935 million

CMRX


3 Biotech Stocks With Notable Insider Buying

Jan 22, 2025, 12:29 PM EST - 2 months ago

3 Biotech Stocks With Notable Insider Buying

AUPH AZN COGT ONC XBI ZYME


3 Oversold Biotech Names

Jan 13, 2025, 12:56 PM EST - 2 months ago

3 Oversold Biotech Names

AVDL FOLD VKTX XBI


Jazz Pharmaceuticals: Should Sing A Better Tune In 2025

Dec 23, 2024, 12:53 PM EST - 3 months ago

Jazz Pharmaceuticals: Should Sing A Better Tune In 2025


Jazz Pharmaceuticals Announces CEO Succession Plan

Dec 16, 2024, 4:05 PM EST - 3 months ago

Jazz Pharmaceuticals Announces CEO Succession Plan


Jazz Pharmaceuticals plc (JAZZ) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 7:40 PM EDT - 8 months ago

Jazz Pharmaceuticals plc (JAZZ) Q2 2024 Earnings Call Transcript


Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?

Jun 20, 2024, 12:29 PM EDT - 10 months ago

Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?